Drug intelligence / Profile preview

KinoPharma coronavirus antiviral

Development stage: Preclinical
Lead developer: KinoPharma
Modality: Small Molecules

Overview

KinoPharma is developing a broad-spectrum antiviral candidate targeting various coronaviruses, including SARS-CoV, MERS-CoV, and SARS-CoV-2. Currently in the preclinical stage, the program aims to treat infections such as COVID-19, SARS, and MERS. While the specific molecular target (e.g., a viral protease or polymerase) is not explicitly disclosed on the company's pipeline, the drug is categorized as an antiviral agent. KinoPharma's broader platform often focuses on small molecule inhibitors of viral replication. The candidate is intended to provide a therapeutic option for both current and potentially emerging coronavirus-related respiratory diseases.

Other names: Coronavirus TreatmentKinoPharma-SARS-CoV-MERS-CoV-SARS-CoV-2-antiviral-COVID-19-SARS-MERS-Other coronavirus infectionsKinoPharma-SARS-CoV-MERS-CoV-SARS-CoV2-antiviral-COVID-19-SARS-MERS-Other coronavirus infectionsKinoPharma-SARS-CoV-MERS-CoV-SARS-CoV 2-antiviral-COVID-19-SARS-MERS-Other coronavirus infections

Beyond the preview

Go deeper on KinoPharma coronavirus antiviral.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KinoPharma coronavirus antiviral.

Explore the full profile